Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ci-Hong Liou"'
Autor:
Po-Yu Liu, Han-Chieh Wu, Ying-Lan Li, Hung-Wei Cheng, Ci-Hong Liou, Feng-Jui Chen, Yu-Chieh Liao
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background Blood cultures are essential for diagnosing bloodstream infections, but current phenotypic tests for antimicrobial resistance (AMR) provide limited information. Oxford Nanopore Technologies introduces nanopore sequencing with adap
Externí odkaz:
https://doaj.org/article/99d28f1ae86440d5bf8a29f40e2c58bf
Autor:
Yu-Chieh Liao, Han-Chieh Wu, Ci-Hong Liou, Tsai-Ling Yang Lauderdale, I-Wen Huang, Jui-Fen Lai, Feng-Jui Chen
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Molecular typing is an essential tool that has been extensively applied in laboratories as well as in clinical settings. Next-generation sequencing technologies promise high-throughput and cost-effective molecular applications; however, the accessibi
Externí odkaz:
https://doaj.org/article/d61c45703ae74ae394e0f6fcac2b7401
Autor:
Yin-Chih Feng, Ci-Hong Liou, Wailap Victor Ng, Feng-Jui Chen, Chih-Hsin Hung, Po-Yen Liu, Yu-Chieh Liao, Han-Chieh Wu, Ming-Fang Cheng
Publikováno v:
Antibiotics, Vol 11, Iss 9, p 1152 (2022)
Third-generation cephalosporin-resistant Escherichia coli (CREC), particularly strains producing extended-spectrum β-lactamases (ESBLs), are a global concern. Our study aims to longitudinally assemble the genomic characteristics of CREC isolates fro
Externí odkaz:
https://doaj.org/article/6d26814040a3463f80bcc79fc08235ce
Autor:
Yu-Kuo Tsai, Ci-Hong Liou, Jung-Chung Lin, Ling Ma, Chang-Phone Fung, Feng-Yee Chang, L Kristopher Siu
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e109258 (2014)
The streptomycin counter-selection system is a useful tool for constructing unmarked in-frame gene deletions, which is a fundamental approach to study bacteria and their pathogenicity at the molecular level. A prerequisite for this system is acquirin
Externí odkaz:
https://doaj.org/article/1a9d0ecfd2cb4e24982d2dac683f831f
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79640 (2013)
Resistance to carbapenems has been documented by the production of carbapenemase or the loss of porins combined with extended-spectrum β-lactamases or AmpC β-lactamases. However, no complete comparisons have been made regarding the contributions of
Externí odkaz:
https://doaj.org/article/b8811f01e5074c579ba84edc8ff2d10b
Autor:
Ci-Hong Liou, 劉啟宏
94
Cryptococcus neoformans is an opportunistic human fungal pathogen which primarily infects immunocompromised patients, such as AIDS, organ transplant, and cancer chemotherapy. Due to its available completed genome sequences, well-developed tra
Cryptococcus neoformans is an opportunistic human fungal pathogen which primarily infects immunocompromised patients, such as AIDS, organ transplant, and cancer chemotherapy. Due to its available completed genome sequences, well-developed tra
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/52645815573919292012
Publikováno v:
Microbial Genomics
Multilocus sequence typing (MLST) is one of the most commonly used methods for studying microbial lineage worldwide. However, the traditional MLST process using Sanger sequencing is time-consuming and expensive. We have designed a workflow that simul
Autor:
Ci-Hong Liou, L. Kristopher Siu, Jung-Chung Lin, Chang-Phone Fung, Feng-Yee Chang, Yu-Kuo Tsai
Publikováno v:
International journal of antimicrobial agents. 55(4)
A total of 50 engineered strains with various antimicrobial resistance mechanisms were constructed by in-frame deletion, site-directed mutagenesis and plasmid transformation from two fully-susceptible strains (Acinetobacter baumannii KAB1544 and ATCC
Autor:
L. Kristopher Siu, H. T. Law, Ci-Hong Liou, Jung-Chung Lin, Kuo-Ming Yeh, Alexander Constantine Bogdan, Michael Dominic Chua, Julian A. Guttman
Publikováno v:
The FASEB Journal. 32
Autor:
Feng-Yee Chang, L. Kristopher Siu, Jung-Chung Lin, Ci-Hong Liou, Chang-Phone Fung, Yu-Kuo Tsai
Publikováno v:
The Journal of antimicrobial chemotherapy. 72(12)
Objectives A strategic system for the screening and testing of new antibiotics was created to facilitate the development of antibiotics that are robustly effective against MDR bacteria. Methods In-frame deletion, site-directed mutagenesis and plasmid